Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037022 · ClinicalTrials.gov registry record · NA
Pivotal Response Treatment Package for Young Children With Autism
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02037022: Completed NA study, sponsored by Stanford University.
NCT02037022 is a NA study that has completed, run by Stanford University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02037022, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a research study examining the effectiveness of a pivotal response treatment package (PRT-P) in targeting language skills in young children with autism.
Interventions
- BEHAVIORAL Pivotal Response Treatment Package (PRT-P)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-12-04 |
| Est. Completion | 2017-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02037022
The ClinicalTrials.gov registry entry for NCT02037022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pivotal Response Treatment Package (PRT-P) is the first listed.
NCT02037022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02037022 about?
NCT02037022 is a clinical study titled "Pivotal Response Treatment Package for Young Children With Autism". This is a research study examining the effectiveness of a pivotal response treatment package (PRT-P) in targeting language skills in young children with autism.
What is the current status of trial NCT02037022?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2013-12-04. Estimated completion is 2017-07-28.
What interventions are being tested in trial NCT02037022?
The interventions under investigation include: Pivotal Response Treatment Package (PRT-P) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02037022?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.